GlassScriptPhysician profile
Brian David Horvath
NPI 1114124666
$1,224.01
in general payments reported to CMS, 2019-2025
16 companies · $27.35 in 2025
The $27.35 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $163 · 2021: $257 · 2022: $483 · 2023: $132 · 2024: $21.84 · 2025: $27.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $151 · Education: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.79 |
| Education | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $459.42 | 2019-2022 | |
| Abbvie INC. | $229.60 | 2019-2022 | |
| Galderma Laboratories, L.P. | $145.48 | 2020 | |
| Sandoz INC. | $62.96 | 2021 | |
| Prugen, INC. Pharmaceuticals | $52.55 | 2019 | |
| Lilly USA, LLC | $45.90 | 2023 | Olumiant |
| Journey Medical Corporation | $42.63 | 2019 | |
| Dermavant Sciences, INC. | $36.30 | 2023-2024 | Vtama |
| Ucb, INC. | $36.19 | 2023 | Bimzelx |
| Leo Pharma INC. | $22.81 | 2022 | |
| Almirall LLC | $20.67 | 2023 | Seysara |
| Verrica Pharmaceuticals INC. | $19.79 | 2025 | Ycanth |
| E.R. Squibb & Sons, L.L.C. | $16.29 | 2022 | |
| Pfizer INC. | $14.38 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $11.48 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $7.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Horvath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.